Rigel pharmaceuticals inc

Major-Pharmaceuticals

RIGL


1180 Veterans Boulevard
South San Francisco , CA 94080

Executive/
Director

Price

  • Last Close
  • $ 0.79
    $ -0.06 -6.62 %
    Jun 26, 2024
  • 52-Week High/Low
  • $1.57 - $0.72
  • YTD
  • -45.5%

  • Trading Volume
  • 25,315
  • Market Cap Full
  • $ 137.8M
  • Shares Outstanding
  • 174.4M
    Nov 2, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 57.3% -31.4% 39.1% -8.8% 11.7% -5% -2.3% 14.2% -12% 2.1%
Q2 -10.1% 7.2% -17.5% -19.8% 2.7% 4% 26.9% -62.6% -2.3% -0.8%
Q3 -23.1% 64.6% -7% 10.3% -30.6% 8% -16.4% 4.4% -16.3% -
Q4 22.7% -35.2% 15.1% -26.8% 22.2% 45.8% -27% 27.1% 40.8% -
J F M A M J J A S O N D
2024 -19.3% 29.9% -2.6% -10.1% - - - - - - - -
2023 9.3% -7.9% -12.6% -14.4% 23.9% -7.9% 7% -17.4% -5.3% -25.3% 41.3% 27.2%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    -20%33%-21%63%-41%-5%61%-24%-43%-3%-46%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.21 0.19 0.13 -0.17 -0.11 0.13 0.22 -0.16 -0.08
Q2 0.16 0.15 0.16 -0.16 -0.12 -0.1 -0.08 -0.08 -0.04
Q3 0.08 0.24 0.14 -0.14 -0.07 -0.08 -0.12 -0.11 -0.03
Q4 0.14 0.16 0.18 0.03 -0.1 -0.13 -0.13 0.01 -
A 0.6 0.7 0.6 -0.4 -0.4 -0.2 -0.1 -0.3 -0.15

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 167.2 168.6 170 171.7 173.7
Jun 163.6 167.2 168.6 170.2 172.1 173.7
Sep 166.4 167.6 168.9 170.9 172.8 174.4
Dec 166.6 167.6 169 171 172.8 174.4

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 0.2 0.1 0.5 1 -
Fixed Asset Turnover 60 49.7 27.3 19.7 22.5
Total Asset Turnover 0.9 0.9 1 0.4 0.3
Leverage
Debt Ratio 0.3 0.1 0.2 0.1 -
Debt – Equity Ratio -2.8 0.7 0.6 0.2 -
Interest Coverage -18.7 -2.6 -29 34.5 24.3
Equity multiplier -0.1 0.1 0.1 0.1 -